So, while in our experimental model of CA-CRC, the milder DSS alone treatment did not reveal a differential colitic response in mutant mice, under prolonged conditions, Irf1 mutant mice can show signs of increased susceptibility to DSS-induced colitis. The gene discussed is IRF1; the disease is cancer.